5th Annual Risk Management and Pharmacovigilance Summit

18 - 20 Sep 2018, Vienna

The 5th Annual Risk Management and Pharmacovigilance Summit will be held in Vienna this coming September and as every year, it will create great atmosphere for PV professionals to network and discuss current issues in the drug safety world. You will hear about all the necessary topics related to the new updates in regulatory, new techniques in digital pharmacovigilance, real examples of benefit-risk evaluation and signal detection, how to go through the inspection, patient support programmes and patient centricity, and many more. Do not forget to highlight the dates 18 - 20 September in your calendar and prepare yourself for 3 days full of great presentations, discussions and networking. We are looking forward to meeting you in the best Pharmacovigilance and Risk Management Summit soon!


Key Speakers

Sabine Jeck-Thole

EU QPPV and Head Regional PV EUCAN & EM

Boehringer Ingelheim


Ariane Stollenwerk

Patient Safety Committee Secretary, QPPV & Alliance office
Grünenthal Group


Rob van Maanen
Senior Medical Director, Medical Science
Astellas

Mónica Marcano
Director Cluster Safety Lead West Europe (France, Portugal & Spain)
Pfizer

Attila Olah
Head Global Pharmacovigilance, QPPV 
Gedeon Richter

Andrea Oliva
Head of pharmacovigilance 
Mylan

Key topics

  • Navigating through PV inspections - from announcement to CAPA
  • Latest trends in Adverse Event Reporting from Social Media
  • Implementation of GVP Rev 2 – Actual experience
  • Multi Criteria Decision Analysis in drug development - practical examples from a development program
  • Could be Pharmacovigilance considered as a thermometer for business?
  • Enhanced EudraVigilance System - future perspectives
  • Benefit-risk evaluation of anticancer medicinal products at entry into human in a changing environment: a review of EMA/CHMP/205/95 Rev.5 guideline
  • Quantitative benefit-risk assessment and patient centricity
  • Patient Support Programmes and Market Research from PV standpoint

 

 

 

 

 

 

 


 

Who Should attend

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, QPPVs, and Heads of departments from pharmaceutical industry / industries involved in:

  • Pharmacovigilance
  • Drug Safety
  • Safety & Risk Management
  • Signal Detection
  • Benefit-Risk Assessment 
  • Safety Evaluation
  • Regulatory Affairs, Pharmacovigilance
  • PV Governance
  • Safety Surveillance
  • Pharmacovigilance Operations
  • PV Inspection and Audit Readiness
  • Patient Support Programs
  • Market Research Programs
  • Clinical Safety 
  • Medical Safety
  • Medical Information 
  • Pharmacoepidemiology

 

1.       Updates on GVP modules

Register for event

Video

Contact

Allan Lloyds Group
Trnavska cesta 82, 821 02 Bratislava, Slovakia

+421 221 025 322

info@allanlloyds.com

Follow us